Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
March 14, 2024 08:15 ET
|
Autonomix Medical, Inc.
First trial to ever evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer THE WOODLANDS, TX, March 14, 2024 (GLOBE NEWSWIRE) --...
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
March 13, 2024 16:05 ET
|
electroCore, Inc.
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY,...
electroCore to Participate in Upcoming Investor Conferences
March 12, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy...
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
March 07, 2024 08:22 ET
|
Neuronetics
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Noah Medical Named a “Fierce 15” Company of 2023 by Fierce MedTech
March 06, 2024 08:00 ET
|
Noah Medical
Medical robotics innovator Noah Medical announced today that Fierce MedTech has named it one of 2023’s “Fierce 15” medical technology companies.
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
March 06, 2024 07:00 ET
|
CytoSorbents
PRINCETON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
February 27, 2024 09:00 ET
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Draper vill förbättra ECMO-behandling med CHS™-coatad produkt
February 27, 2024 04:03 ET
|
Corline Biomedical AB
Draper (The Charles Stark Draper Laboratory Inc.) meddelar att man ingått i partnerskap med US Department of Health and Human Services för att utveckla en innovativ produkt för behandling av akut...
Global Endoscope Reprocessing Market Size is Estimated to Reach USD 4,609 million by 2031, Growing at a CAGR of 8.57%: Straits Research
February 16, 2024 08:00 ET
|
Straits Research
New York, United States, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Endoscope reprocessing is a multi-step process that includes thorough cleaning, disinfection, and sterilization of endoscopes and...
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
February 16, 2024 08:00 ET
|
Autonomix Medical, Inc.
Site initiation completed for first study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer THE WOODLANDS, TX, Feb. ...